Yong Hwan Ahn
Biographic Data
| ID | 4161760 |
|---|---|
| NAME | Yong Hwan Ahn |
| GIVEN NAMES | Yong Hwan |
| FAMILY NAME | Ahn |
| SIGNATURE | AHN Y H |
| AFFILIATIONS | Department of Anatomy & Institute for Environmental Science, Korea. |
| ORCID | 0000-0003-0219-1114 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 1 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2011 |
| H-INDEX | 1 |
Inhibitory Effects of 1',2'-Dihydrorotenone on Osteoclast Differentiation and Bone Resorption In Vitro and In Vivo
It is important to identify therapeutic compounds with no adverse effects for use in the chemotherapy of patients with bone-related diseases. The aim of this study was to identify a new compound that inhibits osteoclast differentiation and bone resorption. Herein, we examined the effects of 1’,2’-dihydrorotenone on osteoclast differentiation and bone resorption in vitro and in vivo. 1’,2’-dihydrorotenone inhibited receptor activator of NF-κB liga…
Inhibitory Effects of 1',2'-Dihydrorotenone on Osteoclast Differentiation and Bone Resorption In Vitro and In Vivo
It is important to identify therapeutic compounds with no adverse effects for use in the chemotherapy of patients with bone-related diseases. The aim of this study was to identify a new compound that inhibits osteoclast differentiation and bone resorption. Herein, we examined the effects of 1’,2’-dihydrorotenone on osteoclast differentiation and bone resorption in vitro and in vivo. 1’,2’-dihydrorotenone inhibited receptor activator of NF-κB liga…
Inhibitory Effects of 1',2'-Dihydrorotenone on Osteoclast Differentiation and Bone Resorption In Vitro and In Vivo
It is important to identify therapeutic compounds with no adverse effects for use in the chemotherapy of patients with bone-related diseases. The aim of this study was to identify a new compound that inhibits osteoclast differentiation and bone resorption. Herein, we examined the effects of 1’,2’-dihydrorotenone on osteoclast differentiation and bone resorption in vitro and in vivo. 1’,2’-dihydrorotenone inhibited receptor activator of NF-κB liga…
Activator (genetics (1 work) · Biochemistry (1 work) · Biology (1 work) · Bone health and treatments (1 work) · Bone marrow (1 work) · Bone Metabolism and Diseases (1 work) · Bone resorption (1 work) · Cancer Research (1 work) · Cell Biology (1 work) · Chemistry (1 work)